Allergic Contact Dermatitis (ACDS) Market Report

Global and Region Allergic Contact Dermatitis (ACDS) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：188
  • REPORT CODE：GMM893877
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Allergic contact dermatitis (ACD) is a common inflammatory skin disorder and an alternative form of contact dermatitis. It is manifestation of allergic responses caused by the contact of an allergic substance such as, nickel, gold, chromium, mercaptobenzothiazole, formaldehyde and many more. The other form of contact dermatitis is irritant contact dermatitis (ICD). Symptoms of allergic contact dermatitis (ACDs) are similar to that of irritant contact dermatitis, which makes the diagnosis harder. The symptoms of allergic contact dermatitis include presence of the skin lesion or rashes at the exposure site. Depending on the allergen type, it may form blisters, papules, simple red spots, vesicles and rashes. The rash can drain, ooze or crust and also becomes raw, thickened or scaled. Allergic contact dermatitis (ACD) is caused as a result of two stages, first stage sensitize and primes the immune system for allergic responses and the second stage, triggers it.   The diagnosis of allergic contact dermatitis includes physical examination and medical therapy. The precise diagnosis based on the symptoms and by rash appearance is very rare. The intermittent or chronic rashes that are not clarified by historical data and physical examination often requires further testing. A patch test (contact delayed hypersensitivity allergy test) is a normally used to detect the actual cause of allergic contact dermatitis.

    The report details the trend, potential and market size of Allergic Contact Dermatitis (ACDS) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Allergic Contact Dermatitis (ACDS)market, defines the market attractiveness level of Allergic Contact Dermatitis (ACDS) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Allergic Contact Dermatitis (ACDS) industry, describes the types of Allergic Contact Dermatitis (ACDS) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Allergic Contact Dermatitis (ACDS) market and the development prospects and opportunities of Allergic Contact Dermatitis (ACDS) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Allergic Contact Dermatitis (ACDS) market in Chapter 13.

    By Player:

    • Sandoz

    • Glenmark Pharmaceuticals

    • Boiron

    • Sanofi

    • Teva Pharmaceuticals

    • Pannoc

    • RENHE

    • Taro Pharmaceuticals

    • Perrigo

    By Type:

    • Glucocorticoids

    • Topical Steroids

    • Miscellaneous Topical Agents

    • Corticosteroid

    • Anticholinergic Antiemetic

    • Miscellaneous Anxiolytics, Sedatives and Hypnotics

    By End-User:

    • Topical Administration

    • Oral Administration

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Allergic Contact Dermatitis (ACDS) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Allergic Contact Dermatitis (ACDS) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Allergic Contact Dermatitis (ACDS) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Allergic Contact Dermatitis (ACDS) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Allergic Contact Dermatitis (ACDS) Market Analysis and Outlook to 2022

    • 7.1 Global Allergic Contact Dermatitis (ACDS) Consumption (2017-2022)

    • 7.2 United States Allergic Contact Dermatitis (ACDS) Consumption (2017-2022)

    • 7.3 Europe Allergic Contact Dermatitis (ACDS) Consumption (2017-2022)

    • 7.4 China Allergic Contact Dermatitis (ACDS) Consumption (2017-2022)

    • 7.5 Japan Allergic Contact Dermatitis (ACDS) Consumption (2017-2022)

    • 7.6 India Allergic Contact Dermatitis (ACDS) Consumption (2017-2022)

    • 7.7 South Korea Allergic Contact Dermatitis (ACDS) Consumption (2017-2022)

    8 Region and Country-wise Allergic Contact Dermatitis (ACDS) Market Analysis and Outlook to 2028

    • 8.1 Global Allergic Contact Dermatitis (ACDS) Consumption Forecast (2022-2028)

    • 8.2 United States Allergic Contact Dermatitis (ACDS) Consumption Forecast (2022-2028)

    • 8.3 Europe Allergic Contact Dermatitis (ACDS) Consumption Forecast (2022-2028)

    • 8.4 China Allergic Contact Dermatitis (ACDS) Consumption Forecast (2022-2028)

    • 8.5 Japan Allergic Contact Dermatitis (ACDS) Consumption Forecast (2022-2028)

    • 8.6 India Allergic Contact Dermatitis (ACDS) Consumption Forecast (2022-2028)

    • 8.7 South Korea Allergic Contact Dermatitis (ACDS) Consumption Forecast (2022-2028)

    9 Global Allergic Contact Dermatitis (ACDS) Market Outlook by Types and Applications to 2022

    • 9.1 Global Allergic Contact Dermatitis (ACDS) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Glucocorticoids Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Topical Steroids Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Miscellaneous Topical Agents Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Corticosteroid Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Anticholinergic Antiemetic Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Miscellaneous Anxiolytics, Sedatives and Hypnotics Consumption and Growth Rate (2017-2022)

    • 9.2 Global Allergic Contact Dermatitis (ACDS) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Topical Administration Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Oral Administration Consumption and Growth Rate (2017-2022)

    10 Global Allergic Contact Dermatitis (ACDS) Market Outlook by Types and Applications to 2028

    • 10.1 Global Allergic Contact Dermatitis (ACDS) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Glucocorticoids Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Topical Steroids Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Miscellaneous Topical Agents Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Corticosteroid Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Anticholinergic Antiemetic Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Miscellaneous Anxiolytics, Sedatives and Hypnotics Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Allergic Contact Dermatitis (ACDS) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Topical Administration Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Oral Administration Consumption Forecast and Growth Rate (2022-2028)

    11 Global Allergic Contact Dermatitis (ACDS) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Allergic Contact Dermatitis (ACDS) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Allergic Contact Dermatitis (ACDS) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Allergic Contact Dermatitis (ACDS) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Allergic Contact Dermatitis (ACDS) Market Competitive Analysis

    • 14.1 Sandoz

      • 14.1.1 Sandoz Company Details

      • 14.1.2 Sandoz Allergic Contact Dermatitis (ACDS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Sandoz Allergic Contact Dermatitis (ACDS) Product and Service

    • 14.2 Glenmark Pharmaceuticals

      • 14.2.1 Glenmark Pharmaceuticals Company Details

      • 14.2.2 Glenmark Pharmaceuticals Allergic Contact Dermatitis (ACDS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Glenmark Pharmaceuticals Allergic Contact Dermatitis (ACDS) Product and Service

    • 14.3 Boiron

      • 14.3.1 Boiron Company Details

      • 14.3.2 Boiron Allergic Contact Dermatitis (ACDS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Boiron Allergic Contact Dermatitis (ACDS) Product and Service

    • 14.4 Sanofi

      • 14.4.1 Sanofi Company Details

      • 14.4.2 Sanofi Allergic Contact Dermatitis (ACDS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Sanofi Allergic Contact Dermatitis (ACDS) Product and Service

    • 14.5 Teva Pharmaceuticals

      • 14.5.1 Teva Pharmaceuticals Company Details

      • 14.5.2 Teva Pharmaceuticals Allergic Contact Dermatitis (ACDS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Teva Pharmaceuticals Allergic Contact Dermatitis (ACDS) Product and Service

    • 14.6 Pannoc

      • 14.6.1 Pannoc Company Details

      • 14.6.2 Pannoc Allergic Contact Dermatitis (ACDS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Pannoc Allergic Contact Dermatitis (ACDS) Product and Service

    • 14.7 RENHE

      • 14.7.1 RENHE Company Details

      • 14.7.2 RENHE Allergic Contact Dermatitis (ACDS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 RENHE Allergic Contact Dermatitis (ACDS) Product and Service

    • 14.8 Taro Pharmaceuticals

      • 14.8.1 Taro Pharmaceuticals Company Details

      • 14.8.2 Taro Pharmaceuticals Allergic Contact Dermatitis (ACDS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Taro Pharmaceuticals Allergic Contact Dermatitis (ACDS) Product and Service

    • 14.9 Perrigo

      • 14.9.1 Perrigo Company Details

      • 14.9.2 Perrigo Allergic Contact Dermatitis (ACDS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Perrigo Allergic Contact Dermatitis (ACDS) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Allergic Contact Dermatitis (ACDS)

    • Figure Allergic Contact Dermatitis (ACDS) Picture

    • Table Global Allergic Contact Dermatitis (ACDS) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Allergic Contact Dermatitis (ACDS) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Allergic Contact Dermatitis (ACDS) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Allergic Contact Dermatitis (ACDS) Consumption by Country (2017-2022)

    • Figure United States Allergic Contact Dermatitis (ACDS) Consumption and Growth Rate (2017-2022)

    • Table Europe Allergic Contact Dermatitis (ACDS) Consumption and Growth Rate (2017-2022)

    • Figure China Allergic Contact Dermatitis (ACDS) Consumption and Growth Rate (2017-2022)

    • Figure Japan Allergic Contact Dermatitis (ACDS) Consumption and Growth Rate (2017-2022)

    • Figure India Allergic Contact Dermatitis (ACDS) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Allergic Contact Dermatitis (ACDS) Consumption and Growth Rate (2017-2022)

    • Figure Global Allergic Contact Dermatitis (ACDS) Consumption Forecast by Country (2022-2028)

    • Figure United States Allergic Contact Dermatitis (ACDS) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Allergic Contact Dermatitis (ACDS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Allergic Contact Dermatitis (ACDS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Allergic Contact Dermatitis (ACDS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Allergic Contact Dermatitis (ACDS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Allergic Contact Dermatitis (ACDS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Glucocorticoids Consumption and Growth Rate (2017-2022)

    • Figure Global Topical Steroids Consumption and Growth Rate (2017-2022)

    • Figure Global Miscellaneous Topical Agents Consumption and Growth Rate (2017-2022)

    • Figure Global Corticosteroid Consumption and Growth Rate (2017-2022)

    • Figure Global Anticholinergic Antiemetic Consumption and Growth Rate (2017-2022)

    • Figure Global Miscellaneous Anxiolytics, Sedatives and Hypnotics Consumption and Growth Rate (2017-2022)

    • Figure Global Topical Administration Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Administration Consumption and Growth Rate (2017-2022)

    • Figure Global Glucocorticoids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Topical Steroids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Miscellaneous Topical Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Corticosteroid Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anticholinergic Antiemetic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Miscellaneous Anxiolytics, Sedatives and Hypnotics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Topical Administration Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Administration Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Allergic Contact Dermatitis (ACDS) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Allergic Contact Dermatitis (ACDS) Export by Region (Top 5 Countries) (2017-2028)

    • Table Sandoz (Foundation Year, Company Profile and etc.)

    • Table Sandoz Allergic Contact Dermatitis (ACDS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sandoz Allergic Contact Dermatitis (ACDS) Product and Service

    • Table Glenmark Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Glenmark Pharmaceuticals Allergic Contact Dermatitis (ACDS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Glenmark Pharmaceuticals Allergic Contact Dermatitis (ACDS) Product and Service

    • Table Boiron (Foundation Year, Company Profile and etc.)

    • Table Boiron Allergic Contact Dermatitis (ACDS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boiron Allergic Contact Dermatitis (ACDS) Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Allergic Contact Dermatitis (ACDS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Allergic Contact Dermatitis (ACDS) Product and Service

    • Table Teva Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceuticals Allergic Contact Dermatitis (ACDS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceuticals Allergic Contact Dermatitis (ACDS) Product and Service

    • Table Pannoc (Foundation Year, Company Profile and etc.)

    • Table Pannoc Allergic Contact Dermatitis (ACDS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pannoc Allergic Contact Dermatitis (ACDS) Product and Service

    • Table RENHE (Foundation Year, Company Profile and etc.)

    • Table RENHE Allergic Contact Dermatitis (ACDS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table RENHE Allergic Contact Dermatitis (ACDS) Product and Service

    • Table Taro Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Taro Pharmaceuticals Allergic Contact Dermatitis (ACDS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Taro Pharmaceuticals Allergic Contact Dermatitis (ACDS) Product and Service

    • Table Perrigo (Foundation Year, Company Profile and etc.)

    • Table Perrigo Allergic Contact Dermatitis (ACDS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Perrigo Allergic Contact Dermatitis (ACDS) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US